"During the seven years from its inception to its gradual growth, it can be said that the company has experienced a leapfrog development process. In addition to the favorable situation of the country's economic development, what is particularly valuable is the firmness and persistence of our team to rise to the challenge and adhere to the road of independent innovation." Mr. Pu's words are full of the bravado of an entrepreneur and the boldness of a scientific researcher.
The end of November 2005, Lepu company officially obtained the State Drug Administration issued the "Rapamycin drug-eluting coronary stent delivery system" product registration certificate, since the formal listing of nearly five months, has produced more than 10,000 drug stents, sales revenue of more than 50 million yuan, only in December 2005, the tax amount of 1.2 million yuan. In December 2005 alone, the company paid taxes of 1.2 million yuan, the economic benefits are very significant, the company in 2004, 2005, compared with the previous year's sales to achieve a 100% increase in sales in 2006 sales are expected to exceed hundreds of millions of dollars.
After 7 years of hard work, LOPE has 22 national patents, 11 Class III medical devices and 2 Class I products issued by the State Food and Drug Administration, with industrialized production capacity of three major categories of cardiovascular interventional, anaesthesia monitoring and care products, including coronary stents, PTCA balloon catheters, arterial sheaths, ultra-smooth guidewires, central venous catheters (CVC, PICC), and other products, which are widely used in the treatment of cardiovascular diseases. The products include coronary stents, PTCA balloon catheters, arterial sheath catheters, ultra-smooth guidewires, central venous catheters (CVC, PICC), pressure transducers, infusion pumps, and blood gas sampling cartridges, etc. Recently, the PARTNER drug-eluting coronary stents have been listed on the market, and the sales network of these products covers all provinces and cities in China except Tibet.
"Where the company's road to the future points to, I believe that in the heart of each and every employee of LP will have a clear direction." Talking about the prospect of the company, Mr. Pu believes that LP will form a good situation of product serialization, brand internationalization, talent echelon and sales network under the premise of double guarantee of technology and quality, utilize the government resources and the technology, talent and market resources that the company already possesses, integrate the existing medical equipment resources in Beijing, break the monopoly of foreign countries, effectively restrain the price of foreign products, and enable more patients in China to truly To make more patients in China can really use interventional medical products widely, and to build a first-class national brand of medical devices in China. It is very important that all products are developed to serve people better and respect people's personality. Nowadays, many high-tech products in the West have to take into account how to better meet the human characteristics and human needs, but also consider whether the production process will cause damage to the human ecological environment, this concept is worth learning from Chinese researchers.
Pu Zhongjie, the head of LOPE, who is founded on honesty, quality and scientific innovation, revealed a strong humanistic complex at the beginning of the interview, which was unexpected, but at the same time deepened the reporter's interest in Pu Zhongjie and his medical career. (Hutchinson Finance original LOPE Medical Devices Co., Ltd. was founded in 1999, by the China Shipbuilding Industry Corporation Seventy-Second Five Research Institute and the U.S. WP company *** with the formation of the capital. As the founder of the company, Mr. Pu Zhongjie has always attached the company to the name of China Shipbuilding. LOPE (Beijing) Medical Devices Co., Ltd. was established in 1999, which was funded by China Shipbuilding Industry Corporation (CSIC) 725 Research Institute and WP Corporation***. The company is mainly engaged in the research and development, production and sales of coronary interventional medical devices, and is one of the few domestic high-end medical devices that can form strong competition with foreign products. Since its establishment, the company has successively completed the research, development and industrialization of a number of interventional medical core products, such as stents and catheters, and was the first one in the industry to obtain the product registration certificate of "Coronary Artery Stent Delivery System" issued by the State Drug Administration (Class III), and the first one to successfully develop and pilot-produce the anti-infection "drug central venous catheter". The first to develop and trial manufacture anti-infective "drug central venous catheter". The main products of LP (Beijing) Medical Devices Co., Ltd. include intravascular drug (rapamycin) eluting stent system, coronary stent delivery system, PTCA balloon dilatation catheter and drug central venous catheter. The main products of the Company's controlling subsidiary, Tiandi Hexie, are anesthesia interventional medical products, sheaths and guidewires for cardiac interventional procedures, etc.; the main products of the Company's controlling subsidiary, Shanghai Shape, are arterial ductus arteriosus (PDA) occluders, atrial septal defect (ASD) occluders, ventricular septal defect (VSD) occluders, etc. LOPE (Beijing) Medical Devices Co., Ltd. owns 9 Class III medical device product registration certificates issued by State Drug Administration, 1 Class II medical device product registration certificate issued by Beijing Drug Administration, 2 Class I medical device product registration certificates issued by Beijing Drug Administration, and 2 product registration certificates that are being applied for approval, and it is an early enterprise in China that has the technology of rapamycin drug stent coating, and is one of the few enterprises in China that has the technology of self-owned stents. It is one of the few domestic enterprises with independent technology to produce and process balloon dilatation catheters and contrast catheters. Around the drug stent and its supporting series of products, the company has 36 patents approved by the state, the application for approval of 30 (of which 4 are applying for international patents).
Shanghai Shape and Shanghai Shape are mainly engaged in the research and development, production and sales of cardiac interventional occluder medical devices, and are one of the major manufacturers of cardiac occluder products in China, with five Class III medical device product registration certificates issued by the State Drug Administration and a total of eight national patents have been obtained.
Tiandi and Xie, the controlling subsidiary of LP (Beijing) Medical Devices Co., Ltd. is mainly engaged in the research, development, production and operation of interventional anesthesia monitoring and interventional accessories and other medical devices, and owns 7 registration certificates for Class III medical devices issued by the State Drug Administration, 1 registration certificate for Class I medical devices issued by Beijing Municipal Food and Drug Administration, and 4 registration certificates for Class II medical devices, and is applying for national patents to be approved. There are 4 national patents pending approval.
The company has established a strict quality management system for medical devices in accordance with the national and medical industry standards GB/T19001 and YY/T0287, and passed the certification in 2004. 2007, the company became the first stent system manufacturer in China to pass the pilot inspection and audit of "Good Manufacturing Practice for Medical Devices" (GMP) implemented by the State Food and Drug Administration (SFDA).
The company has been the first manufacturer of stent systems in China to pass the pilot inspection and audit of GMP implemented by the State Drug Administration.
Leopold (Beijing) Medical Devices Co., Ltd. is located in Changping Science and Technology Park of Zhongguancun Science Park and has been recognized as "Beijing High-tech Enterprise" and "100 Innovative Pilot Enterprises of Zhongguancun Science Park", "Beijing Municipal Enterprise Technology Center", was named "2006 New Material Industry Most Growing Enterprise", and became the executive director of the Surgical Implants Committee of China Medical Devices Industry Association. In January 2009, the company was awarded the third place of "2009 Chinese Potential Enterprises" by Forbes; in March 2009, the company was awarded the title of "Outstanding Contribution Enterprise Unit of the 20th Anniversary of Zhongguancun"; in June 2009, the company was honored with the title of "Beijing Famous Trademark". In June 2009, the company was honored as "Beijing Famous Trademark". Based on the spirit of "integrity, quality, science and innovation", LOPE (Beijing) Medical Devices Co., Ltd. will wholeheartedly provide the best quality products and services for the majority of medical personnel and patients, and endeavor to build a first-class national brand of interventional medical devices in China. On September 18, 2006, we donated 100,000 RMB to China Biomedical Engineering Society.
July 5, 2007, donated 522 coronary stents valued at 6 million yuan to the China Foundation for the Development of Aging, for the China Foundation for the Development of Aging, "Love and Care Fund - Operation Good Heart" large-scale public welfare activities.
In May 2008, all the colleagues of LPKF organized a donation activity of "All for One, Earthquake Relief" to help the victims of Wenchuan Earthquake in Sichuan Province, and donated 32,835 RMB on the same day, which was quickly donated to the disaster area through Beijing Changping Red Cross Society.
In May 2008, in the "Wenchuan Relief Action" carried out by Beijing Red Cross Society, LOPE Medical donated RMB 300,000 yuan, and promptly organized and delivered 100 sets of central venous catheters for intensive care for the relief of the earthquake-stricken areas in Sichuan.
In June 2008, the company donated RMB200,000 to Pengzhou Municipal Health Center through Chengdu Municipal Health Bureau, which was used for disaster relief in the earthquake-stricken areas in Sichuan.
In April 2009, the company launched a donation campaign for congenital heart blockers to help children from poor families nationwide. LP Children's Aid Society donated 1 million dollars for the operation of the project, the Children's Aid Society will surely put this money to good use and make greater contributions to more children in need of assistance. On behalf of the Chinese Association of Social Work, Executive Vice President Yang Jianchang, Vice President and Secretary General Zhao Pengqi and Vice President Liu Liangyu presented a certificate of honor to General Manager Pu Zhongjie to thank LP (Beijing) Medical Devices for its contribution to the field of children's congenital heart disease.
On the morning of March 31, 2010, the donation ceremony between LP and the Children's Aid Committee of the Chinese Association of Social Work was held in the conference room on the third floor of the Chinese Association of Social Work, where Mr. Yang Jianchang, Executive Vice President, Mr. Zhao Pengqi, Vice President and Secretary General, Mr. Liu Liangyu, Vice President, and Wu Jianying, Director General of the Children's Aid Committee of the Chinese Association of Social Work, Ms. Zhang Wen, Deputy Director General, and Ms. Zhang Wen, Deputy Director General of the Children's Aid Committee of the Chinese Association of Social Work. Wang Lingyan, Director of the Office of the "Love - Hope" Medical Program, Zhang Yuhuan, Deputy Director, and Pu Zhongjie, General Manager of Lepu (Beijing) Medical Devices Company Limited, and Zhang Zhibin, General Manager of Shanghai Shape Memory Alloy, etc. *** attended the donation ceremony.
On April 21, 2010, LP issued the first batch of donations of RMB 100,000 to the people affected by the disaster in Yushu through the Red Character Society of Changping District.